{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:51:49Z","timestamp":1793832709494,"version":"4.6.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["945393"],"award-info":[{"award-number":["945393"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008658","name":"Deutsches Krebsforschungszentrum","doi-asserted-by":"publisher","award":["70114707"],"award-info":[{"award-number":["70114707"]}],"id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008658","name":"Deutsches Krebsforschungszentrum","doi-asserted-by":"publisher","award":["CAR DUETT"],"award-info":[{"award-number":["CAR DUETT"]}],"id":[{"id":"10.13039\/100008658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["493624332"],"award-info":[{"award-number":["493624332"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016838","name":"Berlin Mathematical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016838","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002714","name":"Albert-Ludwigs-Universit\u00e4t Freiburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ymthe.2024.05.022","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T11:32:07Z","timestamp":1715686327000},"page":"2357-2372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors"],"prefix":"10.1016","volume":"32","author":[{"given":"Tobias","family":"Bexte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacramioara","family":"Botezatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Miskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenja","family":"Gierschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Moter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Marie","family":"Reindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Campe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Francisco","family":"Villena-Ossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Gebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried S.","family":"Wels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hudecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Ivics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-1192","authenticated-orcid":false,"given":"Evelyn","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.05.022_bib1","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1200\/EDBK_320085","article-title":"CAR T-Cell Therapy in Hematologic Malignancies: Clinical Role, Toxicity, and Unanswered Questions","author":"Gill","year":"2021","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"10.1016\/j.ymthe.2024.05.022_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.05.022_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.15252\/emmm.201607485","article-title":"Clinical development of CAR T\u00a0cells-challenges and opportunities in translating innovative treatment concepts","volume":"9","author":"Hartmann","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2024.05.022_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T\u00a0cell therapy: what we know so far","volume":"20","author":"Cappell","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.05.022_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T\u00a0cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.797440","article-title":"Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions","volume":"10","author":"Alnefaie","year":"2022","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jleuko\/qiad074","article-title":"Non-viral technologies can pave the way for CAR-NK cell therapy","volume":"114","author":"Bexte","year":"2023","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220830","article-title":"Bringing natural killer cells to the clinic","volume":"219","author":"Chiossone","year":"2022","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2024.05.022_bib10","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.022_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.2022016205","article-title":"Engineered and Banked iPSCs for advanced NK and T\u00a0cell immunotherapies","volume":"141","author":"Cichocki","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841107","article-title":"iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting","volume":"13","author":"Goldenson","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.05.022_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2024.05.022_bib15","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3389\/fimmu.2019.03123","article-title":"High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia","volume":"10","author":"M\u00fcller","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2017.226","article-title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","volume":"32","author":"Liu","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2024.05.022_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.2020007748","article-title":"Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells","volume":"137","author":"Daher","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib18","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.2021015184","article-title":"Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia","volume":"140","author":"Cichocki","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1777651","article-title":"Immunotherapy with NK cells: recent developments in gene modification open up new avenues","volume":"9","author":"Reindl","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2024.05.022_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13045-022-01382-5","article-title":"Natural killer cells in clinical development as non-engineered, engineered, and combination therapies","volume":"15","author":"Lamers-Kok","year":"2022","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3179","article-title":"Safe harbours for the integration of new DNA in the human genome","volume":"12","author":"Sadelain","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.022_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ymthe.2019.12.009","article-title":"Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones","volume":"28","author":"Bushman","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gde.2018.06.003","article-title":"Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system","volume":"52","author":"Hudecek","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ymthe.2024.05.022_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2008.11.024","article-title":"Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells","volume":"33","author":"Boissel","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ymthe.2024.05.022_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/cgt.2009.61","article-title":"Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4939-3684-7_19","article-title":"mRNA Transfection to Improve NK Cell Homing to Tumors","volume":"1441","author":"Levy","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2016.00105","article-title":"Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19","volume":"7","author":"Carlsten","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ymthe.2019.03.011","article-title":"Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients","volume":"27","author":"Xiao","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41417-021-00365-x","article-title":"CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model","volume":"29","author":"Ng","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib30","article-title":"Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies","volume":"2018","author":"Matosevic","year":"2018","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.05.022_bib31","article-title":"Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology","volume":"11","author":"Schmidt","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)80436-5","article-title":"Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells","volume":"91","author":"Ivics","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.05.022_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nprot.2008.42","article-title":"A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies","volume":"3","author":"Ng","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2024.05.022_bib34","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1172\/JCI86721","article-title":"Phase I trials using Sleeping Beauty to generate CD19-specific CAR T\u00a0cells","volume":"126","author":"Kebriaei","year":"2016","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.ymthe.2024.05.022_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1032397","article-title":"Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41434-021-00254-w","article-title":"CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma","volume":"28","author":"Prommersberger","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2019-125894","article-title":"Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic Leukemia (B-ALL)","volume":"134","author":"Magnani","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/gt.2011.215","article-title":"Minicircle DNA electrotransfer for efficient tissue-targeted gene delivery","volume":"20","author":"Chabot","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/leu.2016.180","article-title":"Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors","volume":"31","author":"Monjezi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2024.05.022_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/hum.2017.136","article-title":"Efficient Non-Viral T-Cell Engineering by Sleeping Beauty Minicircles Diminishing DNA Toxicity and miRNAs Silencing the Endogenous T-Cell Receptors","volume":"29","author":"Clauss","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ymthe.2018.01.012","article-title":"Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors","volume":"26","author":"Holstein","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","article-title":"Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates","volume":"41","author":"M\u00e1t\u00e9s","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.05.022_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00957","article-title":"Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing","volume":"10","author":"Ingegnere","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-1759(02)00431-3","article-title":"Rapid and highly efficient gene transfer into natural killer cells by nucleofection","volume":"274","author":"Trompeter","year":"2003","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2024.05.022_bib45","first-page":"438","article-title":"Evaluating Electroporation and Lipofectamine Approaches for Transient and Stable Transgene Expressions in Human Fibroblasts and Embryonic Stem Cells","volume":"17","author":"Sharifi Tabar","year":"2015","journal-title":"Cell J."},{"key":"10.1016\/j.ymthe.2024.05.022_bib46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.exphem.2006.05.023","article-title":"Stable gene transfer to human CD34+ hematopoietic cells using the Sleeping Beauty transposon","volume":"34","author":"Hollis","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood-2009-03-210005","article-title":"Stable gene transfer and expression in cord blood\u2013derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system","volume":"114","author":"Xue","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib48","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/hum.2009.109","article-title":"Stable Transgene Expression in Primitive Human CD34+ Hematopoietic Stem\/Progenitor Cells, Using the Sleeping Beauty Transposon System","volume":"20","author":"Sumiyoshi","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s40425-018-0441-8","article-title":"Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells","volume":"6","author":"Wang","year":"2018","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.05.022_bib50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.surg.2019.05.047","article-title":"Engraftment of mesothelin chimeric antigen receptor using a hybrid Sleeping Beauty\/minicircle vector into NK-92MI cells for treatment of pancreatic cancer","volume":"166","author":"Batchu","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.ymthe.2024.05.022_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","article-title":"Human iPSC-derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-Tumor Activity","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.05.022_bib52","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1089\/hum.2017.159","article-title":"Plasmid DNA Manufacturing for Indirect and Direct Clinical Applications","volume":"28","author":"Schmeer","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib53","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41587-019-0291-z","article-title":"A highly soluble Sleeping Beauty transposase improves control of gene insertion","volume":"37","author":"Querques","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ymthe.2005.10.014","article-title":"RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues","volume":"13","author":"Wilber","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.05.022_bib56","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.2021010813","article-title":"Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T\u00a0cells","volume":"138","author":"Bishop","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib57","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood.2021012349","article-title":"Expect the unexpected: piggyBac and lymphoma","volume":"138","author":"Wilson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib58","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood.2021010858","article-title":"Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T\u00a0cells","volume":"138","author":"Micklethwaite","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/mt.2016.11","article-title":"Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4(+) T Cells","volume":"24","author":"Gogol-D\u00f6ring","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib60","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1128\/MCB.25.6.2085-2094.2005","article-title":"High-resolution genome-wide mapping of transposon integration in mammals","volume":"25","author":"Yant","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068201","article-title":"Comparison of Lentiviral and Sleeping Beauty Mediated \u03b1\u03b2 T Cell Receptor Gene Transfer","volume":"8","author":"Field","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2024.05.022_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004250","article-title":"Chromatin Landscapes of Retroviral and Transposon Integration Profiles","volume":"10","author":"de Jong","year":"2014","journal-title":"Plos Genet."},{"key":"10.1016\/j.ymthe.2024.05.022_bib64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/2326-6066.CIR-14-0127","article-title":"The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in\u00a0vivo antitumor activity","volume":"3","author":"Hudecek","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.05.022_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood.2019000905","article-title":"High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy","volume":"134","author":"Hirayama","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib66","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in\u00a0vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.05.022_bib67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.omtm.2018.11.010","article-title":"Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions","volume":"12","author":"Castella","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2024.05.022_bib68","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2081415","article-title":"CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma","volume":"11","author":"Bexte","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ymthe.2024.05.022_bib69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41408-022-00660-2","article-title":"Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia","volume":"12","author":"Albinger","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ymthe.2024.05.022_bib70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.omto.2020.06.014","article-title":"PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model","volume":"18","author":"Alzubi","year":"2020","journal-title":"Mol. Ther. - Oncolytics"},{"key":"10.1016\/j.ymthe.2024.05.022_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02873","article-title":"Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector","volume":"10","author":"Colamartino","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.05.022_bib72","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1093\/nar\/gkac092","article-title":"Engineered Sleeping Beauty transposase redirects transposon integration away from genes","volume":"50","author":"Miskey","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.05.022_bib73","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/mt.2015.149","article-title":"The Role of Neutrophils in Measles Virus\u2013mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF","volume":"24","author":"Dey","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.05.022_bib74","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2017-04-778423","article-title":"SLAMF7-CAR T\u00a0cells eliminate myeloma and confer selective fratricide of SLAMF7+ normal lymphocytes","volume":"130","author":"Gogishvili","year":"2017","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:41:02Z","timestamp":1762548062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1525001624003204"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024","name":"copyright","label":"Copyright"}]}}